BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 35707639)

  • 1. The (Un)real Existence of ADHD-Criteria, Functions, and Forms of the Diagnostic Entity.
    Honkasilta J; Koutsoklenis A
    Front Sociol; 2022; 7():814763. PubMed ID: 35707639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Letter to the Editor: CONVERGENCES AND DIVERGENCES IN THE ICD-11 VS. DSM-5 CLASSIFICATION OF MOOD DISORDERS.
    Cerbo AD
    Turk Psikiyatri Derg; 2021; 32(4):293-295. PubMed ID: 34964106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADHD in the DSM-5-TR: What has changed and what has not.
    Koutsoklenis A; Honkasilta J
    Front Psychiatry; 2022; 13():1064141. PubMed ID: 36704731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of Attention Deficit Hyperactivity Disorder in Intellectual Disability: Diagnostic and Statistical Manual of Mental Disorder V versus clinical impression.
    Perera B; Courtenay K; Solomou S; Borakati A; Strydom A
    J Intellect Disabil Res; 2020 Mar; 64(3):251-257. PubMed ID: 31808234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agreement between Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, and the proposed DSM-V attention deficit hyperactivity disorder diagnostic criteria: an exploratory study.
    Ghanizadeh A
    Compr Psychiatry; 2013 Jan; 54(1):7-10. PubMed ID: 22809622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurodevelopmental Disorders (ASD and ADHD): DSM-5, ICD-10, and ICD-11.
    Doernberg E; Hollander E
    CNS Spectr; 2016 Aug; 21(4):295-9. PubMed ID: 27364515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validity of DSM-IV attention deficit/hyperactivity disorder symptom dimensions and subtypes.
    Willcutt EG; Nigg JT; Pennington BF; Solanto MV; Rohde LA; Tannock R; Loo SK; Carlson CL; McBurnett K; Lahey BB
    J Abnorm Psychol; 2012 Nov; 121(4):991-1010. PubMed ID: 22612200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical practice guidelines for attention-deficit/hyperactivity disorder: recent updates.
    Eom TH; Kim YH
    Clin Exp Pediatr; 2024 Jan; 67(1):26-34. PubMed ID: 37321571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preschoolers classified as having attention-deficit hyperactivity disorder (ADHD): DSM-IV symptom endorsement pattern.
    Byrne JM; Bawden HN; Beattie TL; DeWolfe NA
    J Child Neurol; 2000 Aug; 15(8):533-8. PubMed ID: 10961792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Attention deficit hyperactivity disorder in adults. Benchmarking diagnosis using the Wender-Reimherr adult rating scale].
    Rösler M; Retz W; Retz-Junginger P; Stieglitz RD; Kessler H; Reimherr F; Wender PH
    Nervenarzt; 2008 Mar; 79(3):320-7. PubMed ID: 18210051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parent-reported and clinician-observed autism spectrum disorder (ASD) symptoms in children with attention deficit/hyperactivity disorder (ADHD): implications for practice under DSM-5.
    Grzadzinski R; Dick C; Lord C; Bishop S
    Mol Autism; 2016; 7():7. PubMed ID: 26788284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic controversies in adult attention deficit hyperactivity disorder.
    McGough JJ; Barkley RA
    Am J Psychiatry; 2004 Nov; 161(11):1948-56. PubMed ID: 15514392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medication efficacy: the impact of variability in defining and measuring ADHD and executive functioning.
    Beljan P; Reuter AE; Ganas K; Hoover M
    Appl Neuropsychol Child; 2012; 1(2):152-8. PubMed ID: 23428303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DSM-5 Changes in Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder: Implications for Comorbid Sleep Issues.
    Ramtekkar UP
    Children (Basel); 2017 Jul; 4(8):. PubMed ID: 28749421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and Treatment Options for Preschoolers with Attention-Deficit/Hyperactivity Disorder.
    Wigal S; Chappell P; Palumbo D; Lubaczewski S; Ramaker S; Abbas R
    J Child Adolesc Psychopharmacol; 2020 Mar; 30(2):104-118. PubMed ID: 31967914
    [No Abstract]   [Full Text] [Related]  

  • 17. Predictive validity of ICD-10 hyperkinetic disorder relative to DSM-IV attention-deficit/hyperactivity disorder among younger children.
    Lahey BB; Pelham WE; Chronis A; Massetti G; Kipp H; Ehrhardt A; Lee SS
    J Child Psychol Psychiatry; 2006 May; 47(5):472-9. PubMed ID: 16671930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [DSM-5: neurodevelopmental disorders].
    Zinkstok J; Buitelaar J
    Tijdschr Psychiatr; 2014; 56(3):162-6. PubMed ID: 24643824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of ginkgo preparations for attention deficit hyperactivity disorder: a systematic review protocol.
    He S; Wang M; Si J; Zhang T; Cui H; Gao X
    BMJ Open; 2018 Feb; 8(2):e020434. PubMed ID: 29463592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attention Deficit Hyperactivity Disorder in Prisoners: Increased Substance Use Disorder Severity and Psychiatric Comorbidity.
    Vélez-Pastrana MC; González RA; Ramos-Fernández A; Ramírez Padilla RR; Levin FR; Albizu García C
    Eur Addict Res; 2020; 26(4-5):179-190. PubMed ID: 32615575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.